Our global presence

Our global presence

Ferring has a direct local marketing presence in more than 50 countries worldwide and distribution in 110 countries.

Ferring has R&D centres in 10 countries

Ferring has R&D centres in Brazil, China, Denmark, India, Israel, Japan, Russia, UK, two in Switzerland and three in the US.

The main pharmaceutical development hub is in Copenhagen. The Copenhagen and Parsippany sites drive and execute product innovation and development of new molecular entities as well as further development of our existing in-line products to better meet patient needs or address new disease areas.

Ferring has manufacturing sites in 11 countries

In-house production is carried out in Argentina, China, the Czech Republic, Denmark, Germany, India, Israel, Mexico, Switzerland, the UK and the US.

We invest in necessary facilities and equipment to produce the medicines we discover and make a difference to people’s health and quality of life.

Learn more about our history

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK